Marcela I. Henao-Tamayo, Ph.D.
Affiliations: | 2009 | Colorado State University, Fort Collins, CO |
Area:
Microbiology Biology, ImmunologyGoogle:
"Marcela Henao-Tamayo"Parents
Sign in to add mentor| Ian Orme | grad student | 2009 | Colorado State | |
| (Analysis of T cell subsets induced in response to Mycobacterium tuberculosis infection.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Ali MZ, Dutt TS, MacNeill A, et al. (2023) A Modified BPaL Regimen for Tuberculosis Treatment replaces Linezolid with Inhaled Spectinamides. Biorxiv : the Preprint Server For Biology |
| Dutt TS, Karger BR, Fox A, et al. (2022) Mucosal exposure to non-tuberculous mycobacteria elicits B cell-mediated immunity against pulmonary tuberculosis. Cell Reports. 41: 111783 |
| Silva F, Enaud R, Creissen E, et al. (2022) Mouse Subcutaneous BCG Vaccination and Mycobacterium tuberculosis Infection Alter the Lung and Gut Microbiota. Microbiology Spectrum. e0169321 |
| Maruggi G, Mallett CP, Westerbeck JW, et al. (2022) A self-amplifying mRNA SARS-CoV-2 vaccine candidate induces safe and robust protective immunity in preclinical models. Molecular Therapy : the Journal of the American Society of Gene Therapy |
| Dutt TS, LaVergne SM, Webb TL, et al. (2022) Comprehensive Immune Profiling Reveals CD56 Monocytes and CD31 Endothelial Cells Are Increased in Severe COVID-19 Disease. Journal of Immunology (Baltimore, Md. : 1950). 208: 685-696 |
| Rijkers GT, Weterings N, Obregon-Henao A, et al. (2021) Antigen Presentation of mRNA-Based and Virus-Vectored SARS-CoV-2 Vaccines. Vaccines. 9 |
| Ragan IK, Hartson LM, Dutt TS, et al. (2021) A Whole Virion Vaccine for COVID-19 Produced via a Novel Inactivation Method and Preliminary Demonstration of Efficacy in an Animal Challenge Model. Vaccines. 9 |
| Larsen SE, Reese VA, Pecor T, et al. (2021) Subunit vaccine protects against a clinical isolate of Mycobacterium avium in wild type and immunocompromised mouse models. Scientific Reports. 11: 9040 |
| Tiwari S, Dutt TS, Chen B, et al. (2020) BCG-Prime and boost with Esx-5 secretion system deletion mutant leads to better protection against clinical strains of Mycobacterium tuberculosis. Vaccine |
| Rampacci E, Stefanetti V, Passamonti F, et al. (2020) Preclinical Models of Nontuberculous Mycobacteria Infection for Early Drug Discovery and Vaccine Research. Pathogens (Basel, Switzerland). 9 |